Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03777098 · ClinicalTrials.gov registry record
Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis
A clinical trial of Group A Streptococcal Infection, sponsored by David A. Talan.
- Completed
- Registry status
- 426
- Enrollment target
- 1
- Study location
NCT03777098: Completed study of Group A Streptococcal Infection, sponsored by David A. Talan.
NCT03777098 is a study of Group A Streptococcal Infection that has completed, run by David A. Talan. The registered enrollment target is 426 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03777098, a study of Group A Streptococcal Infection, has completed, sponsored by David A. Talan.
- COMPLETED
- Registry status
- 426 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this pilot study is to acquire images using the Strepic® device, a clinical prototype that has been designed specifically as a viable, low-cost, commercially realizable autofluorescence-based diagnostic test, using (1) fluorescence and (2) white light image data, as well as other clinical data points. By acquiring and analyzing the images of pharyngeal bacterial fluorescence and white light patterns in patients with Group A Streptococcus (GAS)-associated pharyngitis and comparing them with those observed in non-GAS pharyngitis, it is believed an algorithm can be developed such that the device will improve the ability of clinicians to quickly and accurately identify GAS infections.
Primary Outcome
A picture of the participant's throat will be obtained at enrollment.
Conditions Studied
Interventions
- DEVICE Strepic® Device
Study Locations (1)
California
- Olive View-UCLA Medical Center - Sylmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2021-12-30 |
What the finished NCT03777098 record still lists
NCT03777098 is an observational study that tracks outcomes without assigning an intervention. The registered 426 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Group A Streptococcal Infection appearing as the primary indexed condition, and to 1 intervention - of which Strepic® Device is the first listed.
NCT03777098 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03777098 about?
NCT03777098 is a clinical study titled "Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis". The objective of this pilot study is to acquire images using the Strepic® device, a clinical prototype that has been designed specifically as a viable, low-cost, commercially realizable autofluorescence-based diagnostic test, using (1) fluorescence and (2) white light image data, as well as other cl...
What is the current status of trial NCT03777098?
This trial is currently completed. The enrollment target is 426 participants. The study started on 2019-01-02. Estimated completion is 2021-12-30.
What conditions does trial NCT03777098 study?
This clinical trial studies the following conditions: Group A Streptococcal Infection.
What interventions are being tested in trial NCT03777098?
The interventions under investigation include: Strepic® Device (DEVICE).
Who is sponsoring clinical trial NCT03777098?
This trial is sponsored by David A. Talan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03777098 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Group A Streptococcal Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06790784 · 426 participants · Phase 3
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI